• MLKL Polymerization-Induced Lysosomal Permeabilization

  2026-08-31

  The reference study identifies lysosomal membrane permeabilization as a key intermediate in MLKL-driven necroptosis. By combining live-cell imaging, MLKL polymerization experiments, and cathepsin B perturbation, the authors show that lysosomal damage and protease release help connect MLKL activation to irreversible cell death.

• EZ Cap™ Cre mRNA (m1Ψ): Mechanism & Use

  2026-08-31

  EZ Cap™ Cre mRNA (m1Ψ) is a Cre recombinase mRNA designed for loxP-dependent recombination studies. Its m1Ψ nucleosides, Cap 1 structure, poly(A) tail, and defined cold-storage conditions support efficient translation-focused workflows, while delivery and substrate design remain experimental variables.

• Wnt-C59: Practical PORCN Inhibitor Workflows

  2026-08-30

  Wnt-C59 enables controlled inhibition of Wnt ligand secretion for cancer biology, pathway validation, and exosome-mediated osteogenesis studies. This guide connects dose design, reporter assays, cholangiocarcinoma models, and lithium-engineered BMSC exosomes with practical troubleshooting.

• QNZ (EVP4593) as an NF-κB Mechanistic Probe

  2026-08-29

  QNZ (EVP4593) offers a nanomolar tool for dissecting NF-κB signaling pathway modulation beyond routine reporter assays. This article connects its pharmacology to a new HEV–filamin A study and shows how to separate pathway causality from nonspecific cellular stress.

• Maridomycin Antibacterial Activity: Evidence and Methods

  2026-08-28

  The reference study established an integrated in vitro and in vivo profile of maridomycin, combining susceptibility testing, environmental effects, resistance selection, protein-binding analysis, and mouse protection experiments. Its comparison with leucomycin provides a useful historical framework for antibacterial drug discovery, bacterial growth inhibition assay design, and macrolide resistance characterization.

• Maternal Deltamethrin Exposure and Offspring Ferroptosis

  2026-08-28

  A 2025 study links maternal deltamethrin exposure during pregnancy and lactation to impaired hippocampal learning and memory in male rat offspring through a p53-associated ferroptosis pathway. By combining behavioral, histological, biochemical, and HT-22 cell experiments, the work identifies the p53–SLC7A11/GPX4 axis and calcium-homeostasis changes as mechanistic targets for further neurotoxicity research.

• Deferoxamine Mesylate in ROS Research

  2026-08-27

  Deferoxamine mesylate gives researchers a controllable way to reduce labile iron, interrogate oxidative stress, and induce HIF-1α stabilization in cell and tissue models. This article translates those properties into practical workflows for ROS attribution, hypoxia-mimetic assays, wound healing studies, and platinum-drug mechanism testing.

• 25-Hydroxycholesterol Reprograms TAM AMPK–STAT6

  2026-08-27

  Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that accumulates in lysosomes, modulates GPR155–mTORC1 signaling, and activates AMPKα–STAT6-dependent immunosuppressive programming in tumor-associated macrophages. The study links CH25H deficiency to improved T-cell infiltration and stronger anti-PD-1 responses, providing a mechanistic framework for reshaping cold tumor microenvironments.

• Methicillin Sodium Salt in MSSA Research

  2026-08-26

  Build reproducible MSSA susceptibility assays, infection models, and resistance controls with Methicillin sodium salt. This workflow pairs a mechanism-matched bacterial cell wall synthesis inhibitor with quantitative MIC, time-kill, and genotype-aware interpretation.

• Norepinephrine Bitartrate in Renal Hemodynamics

  2026-08-26

  (-)-Norepinephrine (+)-bitartrate is more than a vasopressor reference compound: it can expose how disease state, vascular potassium channels, and assay scale reshape adrenergic responses. This article translates renal perfusion findings into practical decisions for cardiovascular and cardiomyopathy research.

• E-4031 for 3D Cardiac Electrophysiology

  2026-08-25

  E-4031 combines potent hERG inhibition with a practical workflow for exposing arrhythmogenic phenotypes in cardiac organoids. Paired with shell microelectrode arrays, it supports 3D mapping of repolarization, conduction, and drug-induced instability rather than relying on planar or single-cell readouts alone.

• Coumestrol: From Nuclear Receptors to RA Ferroptosis

  2026-08-25

  Coumestrol links estrogen receptor pharmacology with ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes, offering translational researchers a framework for separating receptor activity, cellular mechanism, and therapeutic relevance.

• Esculin in Renal Cell Carcinoma: Mechanism and Evidence

  2026-08-24

  Chen et al. combined network pharmacology, molecular docking, and cell-based validation to investigate how esculin may act against renal cell carcinoma. Their results implicate GAPDH and PI3K/Akt signaling in reduced proliferation and migration and increased apoptosis, while also defining important limitations for translating these findings beyond in vitro models.

• Stat3 in Fyn-Driven Dopaminergic Neurodegeneration

  2026-08-24

  A 2024 zebrafish study identifies Stat3 as a key downstream effector of constitutively active Fyn signaling in dopaminergic neuron loss and microglial inflammation. Its combination of neural-specific genetics, live imaging, transcriptomics, and pathway inhibition provides a mechanistic framework for studying neurodegeneration and inflammatory signaling in vivo.

• Zoledronic Acid Workflows for Cancer Research

  2026-08-23

  Build more reproducible cancer cell apoptosis assays and bone-disease studies with a controlled Zoledronic Acid workflow. This guide connects dose–time screening, solubility management, apoptosis readouts, and the 5T2MM myeloma model while clearly separating established product data from practical optimization recommendations.

8513 records 1/568 page Next 12345 下5页 Last page